Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Shabet Rose Sharon
Relationship:  
City:   Greenwich
State:   CT
   
Insider Summary:
  
   
Companies Owned :   18    
Direct Shares   0    

Indirect Shares

   415,583,308      
Direct Value   $0    

Indirect Value

   $3,624,554,674      
Total Shares   415,583,308      
Total Value   $3,624,554,674      


                                          Charting Not Avaliable
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    8    

     Stock price went up :
    1   
    2    
     Stock price went down :
    0   
    6    
   
     Gain/Loss Ratio :
   1.0   
   1.0   
     Percentage Gain/Loss :
   183.9%
 -174.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Tekmira Pharmaceuticals Corp TKMR 10% Owner 0 2017-07-01 16,013,540    Premium*  
            Sio Gene Therapies Inc SIOX 10% Owner 0 2019-03-18 105,952,381    Premium*  
            Myovant Sciences Ltd. MYOV 10% Owner 0 2019-06-04 40,765,599    Premium*  
            Urovant Sciences Ltd. UROV 10% Owner 2018-10-01 0 2019-06-19 22,860,013    Premium*  
            Adaptive Biotechnologies Corp ADPT 10% Owner 0 2020-12-14 29,993,708    Premium*  
            Bridgebio Pharma, Inc. BBIO 2019-06-27 0 2023-07-18 25,120,991    Premium*  
            Zentalis Pharmaceuticals, Llc ZNTL 10% Owner 0 2020-12-01 3,943,284    Premium*  
            Inhibrx, Inc. INBX 2020-08-24 0 2023-08-28 7,150,826    Premium*  
            4d Molecular Therapeutics Inc. FDMT 2020-12-15 0 2024-01-04 4,247,914    Premium*  
            Rallybio Corp RLYB 10% Owner 2021-07-29 0 2021-07-29 4,194,777    Premium*  
            Figs, Inc. FIGS 10% Owner 2021-09-02 0 2021-09-03 14,742,689    Premium*  
            Procept Biorobotics Corp PRCT 0 2021-09-14 308,142    Premium*  
            Ginkgo Bioworks Holdings, Inc DNA 0 2022-03-02 51,055,144    Premium*  
            Amylyx Pharmaceuticals, Inc. AMLX 2022-01-11 0 2022-01-11 2,300,000    Premium*  
            Frazier Lifesciences Acquisition... FLAC 2022-11-02 0 2022-11-02 1,211,582    Premium*  
            Rayzebio, Inc. RYZB 2023-09-19 0 2024-02-26 0    Premium*  
            Api Group Corp APG 2024-01-02 0 2024-03-05 27,071,548    Premium*  
            Fluidigm Corp FLDM 0 2024-03-18 58,651,170    Premium*  
* Premium Members only  

Records found :    74         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-07 4 AB $7.97 $52,959 I/I 6,649 22,805,109 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-10 4 AB $8.35 $62,594 I/I 7,500 22,812,609 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-11 4 AB $8.58 $61,694 I/I 7,189 22,819,798 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-12 4 AB $8.30 $62,244 I/I 7,500 22,827,298 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-13 4 AB $7.95 $58,543 I/I 7,367 22,834,665 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-14 4 AB $7.91 $56,514 I/I 7,144 22,841,809 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-17 4 AB $8.53 $55,825 I/I 6,541 22,848,350 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-18 4 AB $8.21 $55,061 I/I 6,706 22,855,056 0 -
UROV Urovant Sciences Ltd. 10% Owner   –       –       •   2019-06-19 4 AB $8.17 $40,495 I/I 4,957 22,860,013 0 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2019-06-26 3 IO $0.00 $0 I/I 0 1,425,000 -
BBIO Bridgebio Pharma, Inc. 10% Owner   –       –       •   2019-06-27 4 A $0.00 $0 I/I 21,915,091 21,915,091 0 -
BBIO Bridgebio Pharma, Inc. 10% Owner   –       –       •   2019-06-27 4 B $17.00 $80,000,300 I/I 4,705,900 26,620,991 1.5 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2019-07-01 4 A $0.00 $0 I/I 36,731,607 38,406,607 0 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2019-07-01 4 B $20.00 $5,000,000 I/I 250,000 1,675,000 1.5 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2020-01-28 4 S $24.98 $122,706,039 I/I (4,912,899) 33,493,708 0 %
ZNTL Zentalis Pharmaceuticals,... 10% Owner   –       –       •   2020-04-03 3 IO $0.00 $0 I/I 0 3,718,284 -
ZNTL Zentalis Pharmaceuticals,... 10% Owner   –       –       •   2020-04-07 4 B $18.00 $13,050,000 I/I 725,000 4,443,284 1.5 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-21 3 IO $0.00 $0 I/I 0 4,994,182 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-24 4 B $19.43 $897,001 I/I 46,161 1,161,784 1.5 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-25 4 B $19.23 $1,651,687 I/I 85,304 1,247,088 1.5 -
INBX Inhibrx, Inc. 10% Owner   –       –       •   2020-08-26 4 B $18.84 $3,409,866 I/I 180,219 1,427,307 1.5 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2020-11-11 4 S $49.52 $123,787,500 I/I (2,500,000) 30,993,708 0 %
ZNTL Zentalis Pharmaceuticals,... 10% Owner   –       –       •   2020-12-01 4 S $50.50 $25,250,000 I/I (500,000) 3,943,284 0 -
ADPT Adaptive Biotechnologies ... 10% Owner   –       –       •   2020-12-14 4 S $55.65 $55,650,000 I/I (1,000,000) 29,993,708 0 %
FDMT 4d Molecular Therapeutics... 10% Owner   –       –       •   2020-12-15 4 A $0.00 $0 I/I 2,837,914 2,837,914 0 -
  74  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us